Showing results (1491-1500 of 3,542) with videos related to
Sort By:
Pageof 355
Archiv Der Pharmazie|September 30, 2020
Concise syntheses and some biological activities of dl-2,5-di-O-methyl-chiro-inositol, dl-1,4-di-O-methyl-scyllo-inositol, and dl-1,6-dibromo-1,6-dideoxy-2,5-di-O-methyl-chiro-inositolKadir Aksu, Hulya Akincioglu, Ilhami Gulcin, et al.Archiv Der Pharmazie|November 28, 2018
Design, synthesis, and molecular docking study of benzothiazolotriazine derivatives for anticonvulsant potentialJannat Ul Firdaus, Anwar Habib, Nadeem Siddiqui, et al.Archiv Der Pharmazie|December 1, 2018
Synthesis and in vitro anti-platelet aggregation activities of 2-methoxy-5-arylamido-N-(pyridin-3-yl-methyl)benzamidesYan Wang, Xiao Wang, Xin Chen, et al.Archiv Der Pharmazie|November 13, 2020
Identification of new IDH2R140Q inhibitors by discriminatory analysis-based molecular docking and biological evaluationXiaoyun Chen, Xianmin Wu, Jian Gao, et al.Archiv Der Pharmazie|November 30, 2020
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivativesOmkulthom M Alkamaly, Najla Altwaijry, Rehab Sabour, et al.Archiv Der Pharmazie|October 30, 2020
Protective effect of corynoline in a murine allergic rhinitis model via inhibition of caspase-1/NF-κBLi Wei, Dan Ren, Guna Zhao, et al.Archiv Der Pharmazie|December 31, 2019
Synthesis and anti-inflammatory effects of novel emodin derivatives bearing azole moietiesXiaokang Zhu, Qifang Chen, Yujin Yang, et al.Archiv Der Pharmazie|January 28, 2020
Isatin dimers and their biological activitiesYa-Zhou Zhang, Hong-Zhi Du, Hai-Lin Liu, et al.Archiv Der Pharmazie|July 5, 2014
Synthesis, cytotoxicity, docking study, and tubulin polymerization inhibitory activity of novel 1-(3,4-dimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxanilidesOmar M Aly, Eman A Beshr, Raed M Maklad, et al.Archiv Der Pharmazie|May 7, 2016
Synthesis of Rapamycin Derivatives Containing the Triazole Moiety Used as Potential mTOR-Targeted Anticancer AgentsLijun Xie, Jie Huang, Xiaoming Chen, et al.Pageof 355